These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

686 related items for PubMed ID: 30348604

  • 1. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
    Nahm CB, Turchini J, Jamieson N, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A.
    Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB, Kwon J, Kim YW, Hwang DW, Lee JH, Hong S, Lee JW, Hwang K, Yoo D, Kim SC.
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [Abstract] [Full Text] [Related]

  • 3. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
    Dumont R, Puleo F, Collignon J, Meurisse N, Chavez M, Seidel L, Gast P, Polus M, Loly C, Delvenne P, Meunier P, Hustinx R, Deroover A, Detry O, Louis E, Martinive P, Van Daele D.
    Acta Gastroenterol Belg; 2017 Jun; 80(4):451-461. PubMed ID: 29560639
    [Abstract] [Full Text] [Related]

  • 4. Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study.
    Guo JC, Zhang P, Zhou L, You L, Liu QF, Zhang ZG, Sun B, Liang ZY, Lu J, Yuan D, Tan AD, Sun J, Liao Q, Dai MH, Xiao GG, Li S, Zhang TP.
    EBioMedicine; 2020 May; 55():102767. PubMed ID: 32361251
    [Abstract] [Full Text] [Related]

  • 5. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S, Wei AC.
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [Abstract] [Full Text] [Related]

  • 6. Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.
    Petrushnko W, Gundara JS, De Reuver PR, O'Grady G, Samra JS, Mittal A.
    HPB (Oxford); 2016 Aug; 18(8):652-63. PubMed ID: 27485059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR.
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.
    Martinez-Useros J, Li W, Georgiev-Hristov T, Fernandez-Aceñero MJ, Borrero-Palacios A, Perez N, Celdran A, Garcia-Foncillas J.
    Pathol Oncol Res; 2019 Jan; 25(1):269-278. PubMed ID: 29101736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA, Makowiec F, Chikhladze S, Sick O, Riediger H, Hopt UT, Wittel UA.
    BMC Surg; 2015 Nov 28; 15():123. PubMed ID: 26615588
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C, Yang Z, Li D, Liu Z, Miao X, Yang L, Zou Q, Yuan Y.
    Cancer Biomark; 2015 Nov 28; 15(6):735-43. PubMed ID: 26406402
    [Abstract] [Full Text] [Related]

  • 15. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK, Dhar VK, Wima K, Morris MC, Lee TC, Shah SA, Ahmad SA, Patel SH.
    J Surg Res; 2019 Jul 28; 239():60-66. PubMed ID: 30802706
    [Abstract] [Full Text] [Related]

  • 16. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ, Katz MH, Tzeng CW, Bjørnbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IP.
    Acta Oncol; 2016 Jul 28; 55(3):265-77. PubMed ID: 26213211
    [Abstract] [Full Text] [Related]

  • 17. T-Helper 1 Immune Response in Metastatic Lymph Nodes of Pancreatic Ductal Adenocarcinoma: A Marker For Prolonged Survival.
    Nizri E, Sternbach N, Bar-David S, Ben-Yehuda A, Gerstenhaber F, Ofir T, Wolf I, Weiner G, Lahat G, Klausner J.
    Ann Surg Oncol; 2018 Feb 28; 25(2):475-481. PubMed ID: 29124488
    [Abstract] [Full Text] [Related]

  • 18. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
    Thomas RM, Truty MJ, Kim M, Kang Y, Zhang R, Chatterjee D, Katz MH, Fleming JB.
    Ann Surg Oncol; 2015 Feb 28; 22(6):1884-92. PubMed ID: 25404477
    [Abstract] [Full Text] [Related]

  • 19. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH, Kim H, Hwang JH, Shin E, Lee HS, Hwang DW, Cho JY, Yoon YS, Han HS, Cha BH.
    Pancreas; 2014 Apr 28; 43(3):380-8. PubMed ID: 24622067
    [Abstract] [Full Text] [Related]

  • 20. Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma.
    Zhang SR, Li H, Wang WQ, Jin W, Xu JZ, Xu HX, Wu CT, Gao HL, Li S, Li TJ, Zhang WH, Xu SS, Ni QX, Yu XJ, Liu L.
    Eur J Surg Oncol; 2019 May 28; 45(5):769-775. PubMed ID: 30416079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.